VMI

VHCP Management II Portfolio holdings

AUM $379M
This Quarter Return
+5.54%
1 Year Return
+424.39%
3 Year Return
+2,335.22%
5 Year Return
–
10 Year Return
–
AUM
$166M
AUM Growth
+$166M
Cap. Flow
+$13.1M
Cap. Flow %
7.9%
Top 10 Hldgs %
80.8%
Holding
23
New
1
Increased
3
Reduced
1
Closed
–

Top Buys

1
BCRX icon
BioCryst Pharmaceuticals
BCRX
$2.93M
2
SYRE icon
Spyre Therapeutics
SYRE
$1.53M
3
ARCT icon
Arcturus Therapeutics
ARCT
$1.45M

Top Sells

1
RGNX icon
Regenxbio
RGNX
$251K

Sector Composition

1 Healthcare 85.85%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
AVXS
1
DELISTED
AveXis, Inc. Common Stock
AVXS
$37.8M 22.81% 1,035,657 – –
PDSB icon
2
PDS Biotechnology
PDSB
$57.8M
$19.5M 11.8% 1,933,582 – –
BCRX icon
3
BioCryst Pharmaceuticals
BCRX
$1.74B
$16.2M 9.81% 5,721,142 +1,031,707 +22% +$2.93M
ASND icon
4
Ascendis Pharma
ASND
$11.8B
$9.57M 5.78% 721,152 – –
RGNX icon
5
Regenxbio
RGNX
$451M
$8M 4.83% 999,633 -31,321 -3% -$251K
HRTX icon
6
Heron Therapeutics
HRTX
$207M
$7.33M 4.42% 405,901 – –
ARCT icon
7
Arcturus Therapeutics
ARCT
$462M
$6.53M 3.94% 1,454,402 +323,902 +29% +$1.45M
CTMX icon
8
CytomX Therapeutics
CTMX
$336M
$5.91M 3.56% 577,831 – –
SIOX
9
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$5.52M 3.33% 429,590 – –
AKTX
10
Akari Therapeutics
AKTX
$24.8M
$4.98M 3.01% 369,490 – –
CHRS icon
11
Coherus Oncology, Inc. Common Stock
CHRS
$135M
$4.38M 2.64% 259,259 – –
ONC
12
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$3.55M 2.14% 119,000 – –
ORKA
13
Oruka Therapeutics, Inc. Common Stock
ORKA
$554M
$3.13M 1.89% 1,078,932 – –
GBT
14
DELISTED
Global Blood Therapeutics, Inc.
GBT
$2.83M 1.71% 170,312 – –
STML
15
DELISTED
Stemline Therapeutics, Inc.
STML
$2.14M 1.29% 315,980 – –
OCRX
16
DELISTED
Ocera Therapeutics, Inc.
OCRX
$1.8M 1.09% 948,372 – –
SYRE icon
17
Spyre Therapeutics
SYRE
$996M
$1.53M 0.92% +350,133 New +$1.53M
LPCN icon
18
Lipocine
LPCN
$15.8M
$1.28M 0.77% 420,000 – –
ADVM icon
19
Adverum Biotechnologies
ADVM
$64.6M
$885K 0.53% 280,000 – –
LRMR icon
20
Larimar Therapeutics
LRMR
$310M
$847K 0.51% 141,479 – –
SRRA
21
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$260K 0.16% 130,798 – –